2012 Hemostasis Gordon Research Conference and Gordon Research Seminar

描述(由申请人提供)：我们请求对戈登止血研究会议和戈登止血研究研讨会的部分支持。拟议的会议将于2012年7月22日至27日在华盛顿州沃特维尔山谷的GRC地点举行。2012年的这次会议是自1973年成立以来的第31次此类会议，目前每两年举行一次。2010年的会议被批准与为期一天的戈登研究研讨会同时举行，该研讨会致力于学员介绍和提高他们在GRC的形象。我们很高兴再次获准在2012年止血GRC之前举办为期1天的戈登研究研讨会。止血戈登研究会议汇集了对血小板和凝血蛋白的生物、生化和遗传学感兴趣的科学家、参与治疗出血和血栓性疾病的医生以及来自大小制药公司的研究人员，他们正在开发止血疾病的新疗法。这次会议具有传奇般的地位，使其成为展示尖端研究和揭示该领域重大进展的论坛。事实上，最近在止血方面最引人注目的一些成就是在本系列的前几次会议上首次公布的，或者是由这次会议促进的协作互动推动的。已经同意参加的受邀发言者和讨论领导人名单令人印象深刻，他们代表了该领域的顶级调查人员。这些与会者将增强环境对所有与会者的刺激性质，特别是初级调查人员和受训人员。受欢迎的戈登研究研讨会将大大提高学员对会议的参与度。与以往的会议一样，我们将努力促进妇女和少数群体的参与，并为初级教师、学生、博士后研究员和肢体残疾人士的出席提供便利。该计划目前包括一个以较轻松/一般兴趣的笔记开始会议的历史视角会议和8个会议：1.炎症/感染和凝血；2.血栓形成及其溶解；3.有缺陷的止血；4.血液/血管壁界面；5.受体和信号；6.热点话题摘要谈话；7.血栓形成的调节；8.膜/微粒/动脉粥样硬化。公共卫生相关性：我们请求部分支持戈登研究会议，会议的重点是正常的血液凝固以及在人类疾病中普遍存在的过度出血和血栓形成。这是一次前沿会议，聚集了在影响血液凝结的不同方面进行研究的杰出科学家。这次会议享有国际声誉，是展示该领域新进展的论坛。

DESCRIPTION (provided by applicant): We request partial support for a Gordon Research Conference and Gordon Research Seminar on Hemostasis. The proposed conference is to be held at the GRC site in Waterville Valley, NH, July 22-27, 2012. This conference in 2012 is the 31st such meeting since its inception in 1973 that is now being held biennially. The meeting in 2010 was approved to be held in conjunction with a 1 day Gordon Research Seminar dedicated to trainee presentations and to enhance their profile at the GRC. We are delighted to be again approved to hold the 1 day Gordon Research Seminar to precede the Hemostasis GRC in 2012. The Hemostasis Gordon Research Conference brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have already agreed to participate is impressive and represents top investigators in the field. These attendees will enhance the stimulating nature of the environment for all attendees and especially junior investigators and trainees. Trainee participation in the meeting will be greatly enhanced by the popular Gordon Research Seminar. As in past conferences, we will endeavor to promote participation by women and minorities and facilitate attendance by junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The program currently includes a Historical Perspective Session to begin the meeting on a lighter/general interest note and 8 sessions: 1. Inflammation/Infection and Coagulation; 2. Thrombus Formation and its Dissolution; 3. Defective Hemostasis; 4. Blood/Vessel Wall Interface; 5. Receptors and Signaling; 6. Hot Topic Abstract Talks; 7. Regulation of Thrombus Formation; 8. Membranes/Microparticles/ Atherothrombosis. PUBLIC HEALTH RELEVANCE: We request partial support for a Gordon Research Conference focused on normal blood coagulation as well as excessive bleeding and thrombosis prevalent in human disease. This is a cutting edge conference that brings together outstanding scientists doing research in the diverse facets that affect blood clotting. The meeting enjoys an international reputation for being the forum at which new advances in the field are unveiled.